Literature DB >> 11744908

Vaginal creation for müllerian agenesis.

C P Roberts1, M J Haber, J A Rock.   

Abstract

OBJECTIVE: The purpose of this study was to determine the effectiveness of passive vaginal dilation and McIndoe vaginoplasty in the creation of a neovagina for patients with müllerian agenesis. STUDY
DESIGN: Fifty-one patients with Mayer-Rokitansky-Kuster-Hauser syndrome were treated for vaginal agenesis at either Johns Hopkins Hospital or Emory University. These historic prospective data were obtained by a review of medical records and a current office or telephone consultation. Initial office visits dated from November 18, 1983, through June 6, 1998. Their progress towards both anatomic and functional success was followed through August 1, 2000, which was a range of 2 to 16.8 years. One-way analysis of variance, Student t test, and logistic regression analysis were performed when appropriate.
RESULTS: Four patients were lost to follow-up in various stages of the treatment. Ten patients refused vaginal dilation and proceeded to a successful modified McIndoe vaginoplasty. Of the 37 remaining patients, 91.9% anatomic and functional success was achieved from the Ingram method for vaginal dilation. Passive dilation failed in 8.1% of patients, who underwent a modified McIndoe vaginoplasty; all neovaginal creations were successful. All patients who underwent McIndoe vaginoplasty were compliant with postoperative vaginal form use. None of our patients lost vaginal space through contractions or loss of skin graft. Of those patients for whom dilation failed, only 1 patient discontinued the study because of bleeding and discomfort. In addition, only 1 patient from the 3 cases of failure had undergone a previous hymenotomy. Interestingly, 6 patients for whom dilation was successful (6/34 patients; 17.6%) had also undergone a previous hymenotomy. The mean follow-up time for all patients in this study was 111.1 +/- 7.2 months, with a range of 25 to 188 months. The mean follow-up time for those patients for whom dilation failed or who refused dilation was significantly lower at 64.5 +/- 9.5 and 65.3 +/- 18.5 months, respectively (P <.005). The mean time to successful dilation was 11.8 +/- 1.6 months with a range of 3 to 33 months. Although longer, no statistically significant difference was observed for dilation time in those patients for whom there was a failure to achieve anatomic or functional success (20.5 +/- 12.5 months; range, 8-33 months).
CONCLUSION: These data reveal that passive dilation with the Ingram method is capable of creating an adequate vaginal canal in patients with vaginal agenesis, with respect to both function and anatomy even in those patients with a previous hymenotomy and resultant scar formation. Our modified McIndoe procedure has proved to be an excellent option for patients for whom conservative dilation techniques failed and who refuse to attempt any dilation. Interestingly, our data indicate that patients may now be trending toward immediate surgical correction rather than diligently using dilation techniques to create a vaginal space.

Entities:  

Mesh:

Year:  2001        PMID: 11744908     DOI: 10.1067/mob.2001.119075

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

Review 1.  Dilation and surgical management in vaginal agenesis: a systematic review.

Authors:  Sarah K McQuillan; Sonia R Grover
Journal:  Int Urogynecol J       Date:  2013-10-10       Impact factor: 2.894

2.  Non-surgical treatment of vaginal agenesis using a simplified version of Ingram's method.

Authors:  Mee-Hwa Lee
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

3.  Bowel vaginoplasty in children and young women: an institutional experience with 55 patients.

Authors:  Sundeep Kisku; Lilly Varghese; Aruna Kekre; Sudipta Sen; Sampath Karl; John Mathai; Reju Joseph Thomas; Ravi Kishore
Journal:  Int Urogynecol J       Date:  2015-05-12       Impact factor: 2.894

4.  Consensus in Guidelines for Evaluation of DSD by the Texas Children's Hospital Multidisciplinary Gender Medicine Team.

Authors:  Ganka Douglas; Marni E Axelrad; Mary L Brandt; Elizabeth Crabtree; Jennifer E Dietrich; Shannon French; Sheila Gunn; Lefkothea Karaviti; Monica E Lopez; Charles G Macias; Laurence B McCullough; Deepa Suresh; V Reid Sutton
Journal:  Int J Pediatr Endocrinol       Date:  2010-10-17

5.  The mother of invention-introduction of a novel inflatable stent for McIndoe neovagina.

Authors:  Rebecca K Chung; Joseph Findley; Rebecca L R Flyckt
Journal:  Fertil Steril       Date:  2021-03       Impact factor: 7.490

Review 6.  Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome.

Authors:  Karine Morcel; Laure Camborieux; Daniel Guerrier
Journal:  Orphanet J Rare Dis       Date:  2007-03-14       Impact factor: 4.123

7.  Mayer-Rokitansky-Kuster-Hauser syndrome type II: A rare case.

Authors:  Anand Pai; Mohammad Shakir
Journal:  Indian J Hum Genet       Date:  2013-01

8.  Custom fabricated acrylic vaginal stent as an adjunct to surgical creation of neovagina for a young female with isolated vaginal agenesis.

Authors:  Manu Rathee; Priyanka Boora; Renu Kundu
Journal:  J Hum Reprod Sci       Date:  2014 Oct-Dec

9.  The use of a silicone-coated acrylic vaginal stent in McIndoe vaginoplasty and review of the literature concerning silicone-based vaginal stents: a case report.

Authors:  Ayhan Coskun; Yusuf Kenan Coban; Mehmet Ali Vardar; Ahmet Cemil Dalay
Journal:  BMC Surg       Date:  2007-07-10       Impact factor: 2.102

Review 10.  Mayer-Rokitansky-Kuster-Hauser syndrome: a review.

Authors:  Laura Londra; Farah S Chuong; Lisa Kolp
Journal:  Int J Womens Health       Date:  2015-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.